SAN DIEGO, May 23, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that Jeffrey Black , Chief Financial Officer, will present at two upcoming conferences.
Mr. Black will present at the Second Annual Marcum LLP Microcap Conference on Thursday, May 30, 2013 at the Grand Hyatt Hotel in New York City. The presentation is scheduled to begin at 4:30 p.m. ET and the live webcast of this presentation may be accessed by visiting the "Investors" section of Verenium's website at www.verenium.com. A webcast replay will be available approximately one hour after the live webcast end and will be accessible for 30 days following the conference.
Mr. Black will also present at the upcoming Sidoti & Company, LLC Micro-Cap Conference. The presentation is scheduled to begin at 1:20 p.m. ET on Friday, June 7, 2013 and will take place in New York City. For more information on this conference, or to qualify for attendance, please contact Lynn Orenstein at email@example.com or 212-453-7031.
Verenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes. Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets. Read more at www.verenium.com.
|SOURCE Verenium Corporation|
Copyright©2012 PR Newswire.
All rights reserved